MAPT and early-onset autosomal dominant Alzheimer disease: This suggests that Cdk5-mediated phosphorylation of tau may be decreased in Alzheimer’s disease, whereas due to decreased inhibition by Cdk5 glycogen synthase kinase 3β-mediated tau phosphorylation may be increased (Giese, 2014).